ALK-Abelló A/S (OTC:AKBLF – Get Free Report) shares dropped 4% during trading on Friday . The company traded as low as $17.90 and last traded at $17.90. Approximately 19 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 784 shares. The stock had previously closed at $18.65.
ALK-Abelló A/S Trading Down 4.0 %
The business has a 50-day moving average price of $18.33 and a 200-day moving average price of $14.24.
About ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Further Reading
- Five stocks we like better than ALK-Abelló A/S
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Comprehensive Analysis of PayPal Stock
- 5 Top Rated Dividend Stocks to Consider
- Intuitive Surgical Stock Can Trend Much Higher This Year
- Investing in the High PE Growth Stocks
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
